# NT-3 Levels and Function in Individuals With CMT

> **NCT05011006** · — · NOT_YET_RECRUITING · sponsor: **Zarife Sahenk** · enrollment: 50 (estimated)

## Conditions studied

- Charcot-Marie-Tooth Disease
- Peripheral Neuropathy
- Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DIAGNOSTIC_TEST:** NT3 blood draw

## Key facts

- **NCT ID:** NCT05011006
- **Lead sponsor:** Zarife Sahenk
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-11-13
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05011006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05011006, "NT-3 Levels and Function in Individuals With CMT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05011006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*